Michael Meyers

Chief Executive Officer at

Cell Biotherapy, Inc.

Finance

Health Technology

Consumer Services

Profile

Michael E.
Meyers was the founder of Arcoda Capital Management LP (founded in 2008) and Cell Biotherapy, Inc. (founded in 2016) where he held the title of Chief Executive Officer and Director respectively.
Currently, Mr. Meyers holds the position of Chairman at Ask Melissa LLC and Director at The Jed Foundation.
In the past, he held the position of Chief Executive Officer at Tivorsan Pharmaceuticals, Inc. and Investment Banking Director at Merrill Lynch & Co., Inc. from 1997 to 2000.
He was also a Director at Æterna Zentaris, Inc. from 2011 to 2012, and a Director at Memory Pharmaceuticals Corp.
from 2002 to 2009.
Additionally, he was Vice President-Health Care Investment Banking at Cowen & Co. LLC from 1993 to 1997, Managing Member at Trivium Capital Management LLC from 2002 to 2006, and Manager at GoldenTree Asset Management LP from 2006 to 2008.
Mr. Meyers received his graduate degree from The Trustees of Columbia University in The City of New York and his undergraduate degree from Brandeis University.

Michael Meyers active positions

Companies	Position	Start
The Jed Foundation The Jed Foundation Services to the Health IndustryHealth Services Engages in protecting and supporting emotional health and prevent suicide for nation's teens & young adults	Director/Board Member	-
Cell Biotherapy, Inc. Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics	Chief Executive Officer	2016-02-29
Ask Melissa LLC Ask Melissa LLC Internet Software/ServicesTechnology Services Publishes online lifestyle magazines	Chairman	-

All active positions of Michael Meyers

Former positions of Michael Meyers

Companies	Position	End
Memory Pharmaceuticals Corp. Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Director/Board Member	2009-01-05
GoldenTree Asset Management LP GoldenTree Asset Management LP Investment ManagersFinance GoldenTree is a fundamental value investor with a total-return, catalyst-driven investment process. The firm specializes in opportunities across the credit universe in sectors such as high yield bonds, leveraged loans, distressed debt, structured products, emerging markets, private equity and credit-themed equities.	Portfolio Manager-Equities	2008-01-30
Trivium Capital Management LLC Trivium Capital Management LLC Investment ManagersFinance Trivium is a global long/short opportunistic small-cap investor. They focus on several sectors including, but not limited to, technology, technology services, retail and commercial services. Trivium maintains a high turnover	Chief Investment Officer	2006-09-29
Merrill Lynch & Co., Inc. /Old/ Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Director/Board Member	2000-09-29
Cowen & Co. LLC Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	1996-12-31

See the detail of Michael Meyers's experience

Training of Michael Meyers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Meyers's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Merrill Lynch & Co., Inc. /Old/ Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Finance
Cowen & Co. LLC Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Æterna Zentaris, Inc. Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency	Health Technology
Trivium Capital Management LLC Trivium Capital Management LLC Investment ManagersFinance Trivium is a global long/short opportunistic small-cap investor. They focus on several sectors including, but not limited to, technology, technology services, retail and commercial services. Trivium maintains a high turnover	Finance
Ask Melissa LLC Ask Melissa LLC Internet Software/ServicesTechnology Services Publishes online lifestyle magazines	Technology Services
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
GoldenTree Asset Management LP GoldenTree Asset Management LP Investment ManagersFinance GoldenTree is a fundamental value investor with a total-return, catalyst-driven investment process. The firm specializes in opportunities across the credit universe in sectors such as high yield bonds, leveraged loans, distressed debt, structured products, emerging markets, private equity and credit-themed equities.	Finance
Memory Pharmaceuticals Corp. Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Brandeis University Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Arcoda Capital Management LP Arcoda Capital Management LP Investment ManagersFinance Arcoda Capital Management manages a global healthcare hedge fund. The firm pursues a long-short strategy that is driven by fundamentals. They invest in equity and derivatives issues of companies operating across the global healthcare system. Their investment approach is rooted in sub-sector-specific, detailed fundamental research, which emphasizes a team approach to investments. Arcoda seeks to identify investment opportunities across Value, GARP and Growth companies. Exposure is typically based upon, among other things, the most favorable risk adjusted annualized return opportunities, as modeled by scenario analysis (best, base, worst and burn-down cases). Arcoda's bottom-up, fundamental approach to portfolio construction and exposures is complemented by its application of a top-down overlay which factors technical, environmental, sentiment and macroeconomic indicators to fine tune gross and net exposure.	Finance
The Jed Foundation The Jed Foundation Services to the Health IndustryHealth Services Engages in protecting and supporting emotional health and prevent suicide for nation's teens & young adults	Health Services
Tivorsan Pharmaceuticals, Inc. Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders	Health Technology
Cell Biotherapy, Inc. Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics	Health Technology